About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Abbott Vascular Medical Device Registry | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT04573660

Abbott Vascular Medical Device Registry

The AV-MDR is a prospective, non-randomized, open-label, multi-center registry. The purpose of the AV-MDR study is to proactively collect and evaluate clinical data on the usage of the devices in scop...

Lead sponsor: Abbott Medical Devices•7 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Sharan Dhanjal, MPH

CONTACT

+1 714-926-8292 [email protected]

Chinedu Agbonghai, MS

CONTACT

[email protected]

Sponsors

Lead Sponsor

Abbott Medical Devices

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Subject is at least 18 years of age.
•2. Subject has a planned procedure, or underwent a procedure, that will use/used one or more Abbott target devices covered in this registry.
•3. Subject is willing and able to comply with, or has already completed, the follow-up schedule specified in this protocol.
•4. Subject must provide written informed consent prior to any clinical investigation-related data collection or be enrolled under an IRB/EC approved waiver of consent.

Exclusion Criteria

•1\. Subject has active symptoms and/or a positive test result of COVID-19 or other rapidly spreading novel infectious agent within the prior 2 months of the date of procedure.

Related studies

RECRUITINGPhase 4

Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction

NCT06710184 · NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Acute Myocardial Infarction (AMI)

RECRUITINGPhase 2

Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

NCT05604131 · Acute Myocardial Infarction Type 1

Artificial Intelligence Scalable Solution for ST Myocardial Infarction

NCT06939738 · Acute Myocardial Infarction (AMI)

BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction

NCT04528511 · Atrial Fibrillation New Onset, Acute Myocardial Infarction

Fast Discharge After Acute Myocardial Infarction Discharge MI

NCT06744322 · Acute Myocardial Infarction (AMI)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 3, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment3,784

Start dateOct 2020

Last updatedJul 3, 2025

Condition

Acute Myocardial Infarction Restenoses, Coronary Coronary Artery Lesions Venous Embolism Arterial Embolism

Locations shown

University Hospital - Univ. of Alabama at Birmingham (UAB)

Birmingham, Alabama

Arkansas Heart Hospital

Little Rock, Arkansas

Kaiser Permanente Los Angeles Medical Center

Los Angeles, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 3, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions